Quiza, Kent Phillip R.
HRN: 04-76-07 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/17/2023
METRONIDAZOLE 500MG (TAB)
03/17/2023
03/21/2023
PO
500mg
TID
Amoebiasis
Waiting Final Action